← FDA Drug Approvals (Drugs@FDA)

PREGABALIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: NOVEL LABS INC · Approved 2014-10-23

Drug application

FDA Application #

ANDA202269

Application type

Abbreviated New Drug Application (Generic)

Brand name

PREGABALIN

Generic name

Pregabalin

Active ingredients

PREGABALIN

Dosage form

SOLUTION

Route

ORAL

Marketing status

None (Tentative Approval)

Sponsor

NOVEL LABS INC

First approval

2014-10-23

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown